Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
The lesion also occurs from certain types of toxic fumes, some of the connective tissue diseases, specific types of medications and post respiratory infection. Unusual exposures have also been ...
Historical redlining is linked to care utilization and fragmentation among patients with rheumatic conditions, highlighting the role of structural racism in these disparities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback